In the 12th five year period, LKPC will strive to promote the core competitive strengths so as to be listed as a first class pharmaceutical manufacturer in China. We will continue to follow our corporate strategy and be market oriented. Our management system and adopted science and technology will be innovated to maximize the resource allocation and management effectiveness. We will focus on building three industrial chains in biopharmaceuticals, biological products and biogenetic drugs. Our business will continue to span four modules: human use, veterinary, environmentally friendly products and biopharmaceuticals.
Shandong Lukang Shelile Pharmaceutical Co.,ltd. the veterinary medicine section of Shandong Lukang Pharmaceutical Co., Ltd., was established in 1..
Shandong lukang biological pesticides co., ltd is the innovation , R&D and production base for biopesticide of Shandong Lukang. With registered..
Qinghai Lukang Dadi Pharmaceutical Co. Ltd. was established in 1997, is a subsidiary of Shandong Lukang Pharmaceutical co.,ltd ,with total asset..
Shandong Lukang Pharmaceutical Group Saite Co., Ltd, founded in 1999, is the key production base for multi-species Finished Dosage of Lukang, a..
Shandong Lukang ZeRun Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Shandong Lukang Pharmaceutical Co. Ltd. which is established on t..
Shandong Lukang Zhonghe Environmental Science-Tech Co.,Ltd. founded in July 2005, with the registered capital
of 19.58 million Yuan and fixed as..